Effectiveness of SGLT2 inhibitors in slowing chronic kidney disease progression and reducing mortality: a meta-analysis

Arjun Sharma, Bharat Sharma, Deepthi Sree Vamaraju, Amrendra Kumar Ajay

Open source

DOI
10.3389/fphar.2026.1923548
Published
2026-08-31
Container
Frontiers in Pharmacology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2026.1923548,
  title = {Effectiveness of SGLT2 inhibitors in slowing chronic kidney disease progression and reducing mortality: a meta-analysis},
  author = {Arjun Sharma and Bharat Sharma and Deepthi Sree Vamaraju and Amrendra Kumar Ajay},
  year = {2026},
  journal = {Frontiers in Pharmacology},
  doi = {10.3389/fphar.2026.1923548},
  url = {https://doi.org/10.3389/fphar.2026.1923548}
}

RIS

TY  - JOUR
TI  - Effectiveness of SGLT2 inhibitors in slowing chronic kidney disease progression and reducing mortality: a meta-analysis
AU  - Arjun Sharma
AU  - Bharat Sharma
AU  - Deepthi Sree Vamaraju
AU  - Amrendra Kumar Ajay
PY  - 2026
JO  - Frontiers in Pharmacology
DO  - 10.3389/fphar.2026.1923548
UR  - https://doi.org/10.3389/fphar.2026.1923548
ER  - 

APA

Sharma, A., Sharma, B., Vamaraju, D. S., & Ajay, A. K. (2026). Effectiveness of SGLT2 inhibitors in slowing chronic kidney disease progression and reducing mortality: a meta-analysis. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2026.1923548

Source records